ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0292

Exhausted pSTAT5-IFNα Signaling Pathways in SLE Patients Are Correlated with Age-associated B Cells and Disease Activity

Samantha Slight-Webb1, Miles Smith2, Kevin Thomas1, Susan Macwana1, Holden Maecker3, Paul Utz4, Judith James5 and Joel Guthridge1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Oklahoma Medical Research Foundation, Oklahoma City, 3Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, 4Stanford University School of Medicine, Stanford, CA, 5Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation;Department of Pathology, University of Oklahoma Health Sciences Center;Department of Medicine, University of Oklahoma Health Sciences Center, Edmond, OK

Meeting: ACR Convergence 2020

Keywords: B-Lymphocyte, Cell-signalling molecules, cytokines, interferon, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: SLE – Etiology & Pathogenesis Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by periods of elevated and suppressed clinical symptoms. Specific cell subsets, such as CD11c+ age-associated B cells (ABCs) have been associated with SLE pathogenesis. While TLR7 and TLR9 are thought to be prerequisites for ABC differentiation, the signaling pathways involved in driving SLE disease activity and ABC generation are still unclear.

Methods: Peripheral whole blood of healthy controls (n=18) and SLE patients with variable disease activity (n=40) were stimulated for 15 minutes with either interferon-α (IFNα), PMA and ionomycin, or Toll-like receptor (TLR) ligands for TLR4, TLR7/8 or TLR9 for phospho-protein analysis. Phenotype and phospho-protein markers were assessed by mass cytometry and cell heterogeneity was analyzed using t-SNE and manual gating. Plasma cytokines were assessed by 37-plex xMAP assays and ELISAs. SELENA-SLEDAI scores were used to correlate phenotype and functional differences with disease activity. All SLE patients met ACR classification criteria.

Results: Basal levels of pSTAT5 in CD4+ (p=0.0094) and CD8+ T cells (p=0.0289), pSTAT1 in B cells (p=0.0246), and cCASP3 in NK cells (p=0.0155) were elevated in SLE patients compared to controls. Following whole blood stimulation, a reduced fold change in pSTAT5 expression following IFNα whole blood stimulation was the primary signaling marker altered in SLE patients with high disease activity (SLEDAI≥4)  compared to low disease activity (SLEDAI< 4)  (p< 0.05). Most significantly, monocyte pSTAT5 IFNα-induced fold change in expression was negatively correlated with disease activity scores in SLE patients (p=0.0164) (Figure 1A). CD11c+ age-associated B cells had the strongest positive correlation with SLEDAI out of all 45 cell phenotypes assessed (p=0.0144) (Figure 1B), followed closely by HLA-DR+ CD4+ T cells (p=0.0186). A reduced fold change of pSTAT5 IFNα-induced expression in pDCs (p=0.0058), B cells (p=0.0116), and monocytes (p=0.0214) was negatively correlated with ABCs frequencies, while basal levels of pSTAT5 in pDCs, B cells, and NK cells were positively correlated with ABCs (Figure 1C, D, and E). Basal pSTAT1 levels and pSTAT1 IFNα-induced fold changes were not correlated with ABCs. Basal pSTAT5 expression in whole blood was associated with higher plasma levels of BLyS (p=0.02 x108), TNFα (p=0.02×107), IL-8 (p=0.01×103), IL-10 (p=0.00010), IL-6 (p=0.00011), SCF (p=0.0006), IL-22 (p=0.0007), and IL-31 (p=0.0018). ABCs frequencies were also strongly correlated with TNF-β (p=0.0019) plasma levels in SLE.

Conclusion: ABCs are highly correlated with disease activity and exhausted pSTAT5 IFNα-induced signaling in pDCs and other antigen-presenting cells suggesting an important role for this pathway in lupus pathogenesis and ABC differentiation.

Figure 1. pSTAT5-IFNa signaling pathways are associated with age-associated B cells (ABCs). Whole blood of 58 subjects, either controls or SLE patients with variable disease activity, were used for phenotype analysis by mass cytometry. T-distributed stochastic neighbor embedding (tSNE) was used to visualize and cluster cells that were most similar using 28 surface markers. B cells or monocytes were gating and a second tSNE visualization was rendered to cluster and differentiate B cells or monocytes (A, B). pSTAT5 signaling was strongly reduced in monocytes following IFNa stimulation suggesting exhaustion of this pathway from persistent activation, and this was positively correlated with SLEDAI (A). CD11c+ ABC frequencies were higher in SLE patients, and correlated with lupus disease activity (B). Basal levels of pSTAT5 in pDCs (C), B cells (D), and NK cells (E) were correlated with ABC frequencies.


Disclosure: S. Slight-Webb, None; M. Smith, None; K. Thomas, None; S. Macwana, None; H. Maecker, None; P. Utz, None; J. James, Progentec Diagnostics, Inc., 9; J. Guthridge, None.

To cite this abstract in AMA style:

Slight-Webb S, Smith M, Thomas K, Macwana S, Maecker H, Utz P, James J, Guthridge J. Exhausted pSTAT5-IFNα Signaling Pathways in SLE Patients Are Correlated with Age-associated B Cells and Disease Activity [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/exhausted-pstat5-ifn%ce%b1-signaling-pathways-in-sle-patients-are-correlated-with-age-associated-b-cells-and-disease-activity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/exhausted-pstat5-ifn%ce%b1-signaling-pathways-in-sle-patients-are-correlated-with-age-associated-b-cells-and-disease-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology